Anti-cancer Membranes
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT04619056
First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 3, 2020
Completion: May 15, 2025
NCT06538857
CEB-01 in Locally Resectable Pancreatic Cancer
Phase: Phase 2
Start: Aug 20, 2024
Completion: Sep 30, 2028
NCT06986811
CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours
Start: May 6, 2025
Completion: May 31, 2029
Loading map...